Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Titel:
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Auteur:
Kim, Hye Jin Yoon, Sung-Soo Lee, Dong Soon Sohn, Sang Kyun Eom, Hyeon Seok Lee, Jung Lim Chung, Joo Seup Kim, Kihyun Suh, Cheolwon Won, Jong Ho Kim, Jin Seok Park, Joon Seong Kang, Hye Jin Seong, Chu Myong Kim, Cheol Soo Lee, Sang Jae Lee, Jae Hoon